Initiation of Insulin in Patients With Type 2 Diabetes Failing Oral Therapy
Response to Raskin et al. and Mikhail and Cope
- Hans U. Janka, MD
- Klinikum Bremen-Nord, Bremen, Germany
- Address correspondence to Prof. Hans U. Janka, Klinikum Bremen-Nord, 2nd Medizinische Abteilung, Hammersbecker Str. 228, 28755 Bremen, Germany. E-mail: hans.janka{at}klinikum-bremen-nord.de
Our previous publication regarding the initiation of insulin therapy in patients with type 2 diabetes failing oral therapy (1) and the recent study by Raskin et al. (2) has raised interesting discussion (3,4). Raskin et al. reported that glycemic control was better in patients treated with BIAsp 70/30 plus oral antidiabetic agents (OADs) than in those receiving insulin glargine plus OADs (mean end point HbA1c 6.91 vs. 7.41%). In contrast, we demonstrated that glycemic control was better in patients treated with insulin glargine plus OADs compared …
